PSI Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

PSI Advisors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,500	Closed	-$737	–	901
2023 Q2	$737	Hold	3,500	–	–	﹤0.01%	751
2023 Q1	$560	Hold	3,500	–	–	﹤0.01%	710
2022 Q4	$1.94K	Hold	3,500	–	–	﹤0.01%	608
2022 Q3	$4K	Hold	3,500	–	–	﹤0.01%	569
2022 Q2	$2K	Hold	3,500	–	–	﹤0.01%	686
2022 Q1	$4K	Hold	3,500	–	–	﹤0.01%	583
2021 Q4	$8K	Hold	3,500	–	–	﹤0.01%	542
2021 Q3	$12K	Buy	+3,500	New	+$10.8K	0.01%	466

Other funds holding INFI

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

PSI Advisors's INFI Position: Q3 2023 in Review

PSI Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 3,500 shares — an estimated $737 sold.

PSI Advisors first reported a position in INFI in Q3 2021 and held it in 8 quarters. The position peaked at $12K in Q3 2021. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

PSI Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
PSI Advisors sold 3,500 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $737.
PSI Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2021 and held it in 8 quarters.
PSI Advisors's Infinity Pharmaceuticals, Inc. position peaked at $12K in Q3 2021.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on PSI Advisors's 13F filing for Q3 2023, filed 13 Oct 2023.